Ethosuximide
Brand names
Usage
To control seizures in patients
with certain types of epilepsy.
How it works
Ethosuximide acts on the central nervous system to control
the number and severity of
seizures. It is thought to
depress the activity of certain
parts of the brain and suppress the abnormal
transmission of nerve impulses that
causes absence seizures.
Side effects
- Serious
- Sore throat,
fever, swollen glands, red or purple
point like rash on the skin or mucous membranes, blistering or
peeling skin lesions, mouth sores, easy bruising, paleness,
weakness, confusion, lethargy, muscle pain, or seizures
may be a sign of a potentially fatal
blood reaction or other
complication.
- Common
- Nausea and vomiting,
loss of appetite, stomach upset,
gastrointestinal cramps, weight loss,
diarrhea, sedation, mild
sensory nerve impairment.
- Less common
- Irritability, headache,
dizziness, sleep disturbances. There
are numerous additional side effects associated with the
use of this medicament; consult your physician if you are
concerned about any adverse or unusual reactions.
Possible interactions
- Other medicaments:
Ethosuximide may increase the effects of:
- phenytoin (Dilantin) and fosphenytoin (Cerebyx), by slowing elimination.
Ethosuximide taken concurrently with:
- carbamazepine (Tegretol) may change ethosuximide blood levels.
- phenobarbital may decrease seizure control success.
- ritonavir (Norvir) and perhaps other protease inhibitors
may lead to toxicity.
- tramadol (Ultram) may increase seizure risk.
- valproic acid (Depakene) may unpredictably alter ethosuximide effects.
The following medicament may increase the effects of ethosuximide:
- isoniazid (INH, Niconyl, etc.).
- Herbal medicines or minerals:
- Valerian and
kava kava may interact additively
(drowsiness). Avoid these combinations.
- Alcohol:
- Use caution-this medicament may increase the sedative effects of
alcohol.
Excessive alcohol may precipitate seizures.
- Discontinuation:
- Do not stop taking this medicament abruptly. Ask your physician for
help with gradual dose reduction.
|